Analysis shows corporate governance and institutional investors impact IPO survival rates, indicating importance of stakeholder collaboration.
Research Question/Issue This study investigates the role of CEO social capital, director networks, and anchor investor participation in influencing the short‐ and long‐term performance outcomes of initial public offerings (IPOs) in the Hong Kong stock market. Research Findings/Insights Studying a sample of 1155 IPOs listed in Hong Kong from 2004 to 2019, we find that highly connected CEOs and boards significantly enhance short‐term IPO performance as measured by demand multiples. We find that anchor investors' participations strengthen the positive performance of the IPO firms. We show that the positive effects of CEO and board networks are beyond the short‐term outcomes and significantly contribute to enhanced operating performance, higher market‐adjusted returns, and higher survival rates post listing. These results are robust to endogeneity concerns and shed further light on the value of social capital and anchor investors' participation for IPO firms. Theoretical/Academic Implications This study advances corporate governance research by highlighting the critical role of social capital in IPO success, particularly for a well‐regulated market outside the United States and Europe. It extends the literature on board and executive networks by demonstrating their complementary relationship with institutional investors, such as anchor investors, in enhancing both short‐ and long‐term IPO outcomes. Practitioner/Policy Implications The findings underscore the importance of leveraging CEO and board networks alongside unique institutional (i.e., anchor) investors to boost IPO success. Policymakers and stock exchange regulators can draw on these insights to design regulatory frameworks that foster stakeholder collaboration, reduce information asymmetry, and promote better governance practices in IPO markets.
No takes yet. Share an insight, caveat, or question.
Abdulkadir Mohamed (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: